Tech Company Financing Transactions
Targazyme Funding Round
On 7/16/2009, Targazyme raised $2.5 million in funding from Texas Emerging Technology Fund.
Transaction Overview
Company Name
Announced On
7/16/2009
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2100 Palomar Airport Rd. 214-19
Carlsbad, CA 92011
USA
Carlsbad, CA 92011
USA
Phone
Website
Email Address
Overview
Targazyme is a privately held biotechnology company dedicated to the development and commercialization of enabling technologies to enhance and expand the therapeutic potential of stem cell transplants.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lynnet Koh
VP - Operations
Richard Martin
VP - Regulatory Affairs
Audrey Jakubowski
Browse more venture capital transactions:
Prev: 7/16/2009: Aloqa venture capital transaction
Next: 7/16/2009: Invodo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs